PA Medical News about cost effectiveness

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness
Health Economics, 04/30/09

Shiroiwa T et al. - Although the threshold of cost effectiveness of medical interventions is thought to be £20 000-£30 000 in the UK, and $50 000-$100 000 in the US, it is well known that these values are unjustified, due to lack of explicit scientific evidence. The authors suggest new classification of cost-effectiveness plane and methodology for decision making.

Complementing the net benefit approach: A new framework for Bayesian cost-effectiveness analysis
International Journal of Technology Assessment in Health Care, 11/05/09 Relevance Score: 69%

Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation
Annals of Internal Medicine, 11/04/09 Relevance Score: 69%

Economic evaluation of arthritis self management in primary care
British Medical Journal, 10/08/09 Relevance Score: 69%

Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions: A Comparison of Britain, Australia, and Canada
JAMA, 10/07/09 Relevance Score: 68%

Cost-effectiveness analysis of trastuzumab (herceptin) in HER2-overexpressed metastatic breast cancer
American Journal of Clinical Oncology, 10/06/09 Relevance Score: 68%